These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31076838)

  • 1. A new role for oligodendrocytes and myelination in schizophrenia and affective disorders?
    Schmitt A; Simons M; Cantuti-Castelvetri L; Falkai P
    Eur Arch Psychiatry Clin Neurosci; 2019 Jun; 269(4):371-372. PubMed ID: 31076838
    [No Abstract]   [Full Text] [Related]  

  • 2. White matter changes in schizophrenia: evidence for myelin-related dysfunction.
    Davis KL; Stewart DG; Friedman JI; Buchsbaum M; Harvey PD; Hof PR; Buxbaum J; Haroutunian V
    Arch Gen Psychiatry; 2003 May; 60(5):443-56. PubMed ID: 12742865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding aberrant white matter development in schizophrenia: an avenue for therapy?
    Walterfang M; Velakoulis D; Whitford TJ; Pantelis C
    Expert Rev Neurother; 2011 Jul; 11(7):971-87. PubMed ID: 21721915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione deficit impairs myelin maturation: relevance for white matter integrity in schizophrenia patients.
    Monin A; Baumann PS; Griffa A; Xin L; Mekle R; Fournier M; Butticaz C; Klaey M; Cabungcal JH; Steullet P; Ferrari C; Cuenod M; Gruetter R; Thiran JP; Hagmann P; Conus P; Do KQ
    Mol Psychiatry; 2015 Jul; 20(7):827-38. PubMed ID: 25155877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelination deficit in a phencyclidine-induced neurodevelopmental model of schizophrenia.
    Zhang R; He J; Zhu S; Zhang H; Wang H; Adilijiang A; Kong L; Wang J; Kong J; Tan Q; Li XM
    Brain Res; 2012 Aug; 1469():136-43. PubMed ID: 22750584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelin, myelin-related disorders, and psychosis.
    Mighdoll MI; Tao R; Kleinman JE; Hyde TM
    Schizophr Res; 2015 Jan; 161(1):85-93. PubMed ID: 25449713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies?
    Sokolov BP
    Int J Neuropsychopharmacol; 2007 Aug; 10(4):547-55. PubMed ID: 17291372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter and cognitive function in schizophrenia.
    Dwork AJ; Mancevski B; Rosoklija G
    Int J Neuropsychopharmacol; 2007 Aug; 10(4):513-36. PubMed ID: 17313699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origin and dynamics of oligodendrocytes in the developing brain: Implications for perinatal white matter injury.
    van Tilborg E; de Theije CGM; van Hal M; Wagenaar N; de Vries LS; Benders MJ; Rowitch DH; Nijboer CH
    Glia; 2018 Feb; 66(2):221-238. PubMed ID: 29134703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelination-related genes are associated with decreased white matter integrity in schizophrenia.
    Chavarria-Siles I; White T; de Leeuw C; Goudriaan A; Lips E; Ehrlich S; Turner JA; Calhoun VD; Gollub RL; Magnotta VA; Ho BC; Smit AB; Verheijen MH; Posthuma D
    Eur J Hum Genet; 2016 Mar; 24(3):381-6. PubMed ID: 26014434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelin and oligodendrocyte lineage cells in white matter pathology and plasticity after traumatic brain injury.
    Armstrong RC; Mierzwa AJ; Sullivan GM; Sanchez MA
    Neuropharmacology; 2016 Nov; 110(Pt B):654-659. PubMed ID: 25963414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Healthy and Diseased Microenvironments Regulate Oligodendrocyte Properties: Implications for Regenerative Medicine.
    Leferink PS; Heine VM
    Am J Pathol; 2018 Jan; 188(1):39-52. PubMed ID: 29024633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Disturbance of oligodendrocyte differentiation in schizophrenia in relation to main hypothesis of the disease].
    Kolomeets NS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):108-117. PubMed ID: 28884727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of synaptic connectivity reduction for pathogenesis, clinical picture and course of schizophrenia].
    Rabe-Jabłońska J
    Psychiatr Pol; 2003; 37(6):951-64. PubMed ID: 14727368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological underpinnings of treatment resistance in schizophrenia: an hypothesis.
    Bartzokis G; Altshuler L
    Psychopharmacol Bull; 2003; 37(4):5-7. PubMed ID: 15272475
    [No Abstract]   [Full Text] [Related]  

  • 16. The Genomic Intersection of Oligodendrocyte Dynamics in Schizophrenia and Aging Unravels Novel Pathological Mechanisms and Therapeutic Potentials.
    Rivera AD; Normanton JR; Butt AM; Azim K
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligodendrocyte pathophysiology: a new view of schizophrenia.
    Segal D; Koschnick JR; Slegers LH; Hof PR
    Int J Neuropsychopharmacol; 2007 Aug; 10(4):503-11. PubMed ID: 17291369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction to the special section: Myelin and oligodendrocyte abnormalities in schizophrenia.
    Haroutunian V; Davis KL
    Int J Neuropsychopharmacol; 2007 Aug; 10(4):499-502. PubMed ID: 17583597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced mitochondrial autophagy (mitophagy) in oligodendrocytes might play a role in white matter pathology in schizophrenia.
    Bernstein HG; Keilhoff G; Dobrowolny H; Steiner J
    Med Hypotheses; 2020 Jan; 134():109443. PubMed ID: 31644973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders.
    Vostrikov VM; Uranova NA; Orlovskaya DD
    Schizophr Res; 2007 Aug; 94(1-3):273-80. PubMed ID: 17566708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.